What are the differences between CAR T-cell therapy and bispecific antibodies?

In this week’s #AskDrDurie, myeloma expert Dr. Brian G.M. Durie discusses the main differences between the CAR T cells and bispecific monoclonal antibodies. The BOTTOM LINE: Discuss with your doctor to decide which treatment is available and appropriate for you. _______________ Improving Lives | Finding the Cure Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy. Subscribe to our channel:    / imfmyeloma   Visit our website at: https://www.myeloma.org Find us online: Facebook: @myeloma |   / myeloma   Twitter: @IMFMyeloma |   / imfmyeloma   Instagram: @imfmyeloma |   / imfmyeloma   LinkedIn:   / international-myeloma-foundation   Support the IMF | Donate Now! https://secure.myeloma.org/page/40697... Category Nonprofits & Activism License Standard YouTube License In most cases, captions are autogenerated by YouTube.